trial

Efficacy and Safety of tACS vs tDCS in Schizophrenia

NCTId NCT06494124
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 90 (estimated)
Sponsored by All India Institute of Medical Sciences, Bhubaneswar
Primary completion 2026-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2024-04-03
Primary completion
2026-04
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
transcranial alternating current stimulation (tACS)transcranial direct current stimulation (tDCS)

Sponsors

All India Institute of Medical Sciences, BhubaneswarLead Sponsor
Indian Council of Medical ResearchCollaborator

Sites

1 total
Bhubaneswar, India

Facts & assertions

4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2026-04
Status
RECRUITING
relationships
The graph out of here
drug
transcranial alternating current stimulation (tACS)
drug
transcranial direct current stimulation (tDCS)
drug
lead_sponsor
All India Institute of Medical Sciences, Bhubaneswar
company
collaborator
Indian Council of Medical Research
company
indication
Schizophrenia
indication
Schizophrenia
indication